This video was originally produced for internal use at Roche
PROGRAMME PARTNERS:
WHERE:
Kagera Region, Tanzania. Varanasi Division, India. Rwenzori Region, Uganda
WHEN:
September 2015 – ongoing
SHARED VISION:
Reducing deaths from cervical cancer.
IMPACT:
Please click here to access our reflections and learnings from 2015 - 2020
The NJIA Programme has been running in Uganda since 2021, click here for a summary this work
WHY:
Tanzania has the highest reported number of cervical cancer cases in East Africa. It is a leading cause of death among women, with 4,200 women dying of cervical cancer annually.
One woman dies every six minutes from cervical cancer in India. More women die from cervical cancer in India than in any other country.
Cervical cancer is 90% preventable with effective vaccination, screening and treatment programmes.
HOW:
Pepal leads this multi-stakeholder and multi-national partnership. NJIA brings together senior leaders from F. Hoffmann-La Roche AG (international pharmaceutical company), NGO partners, and the Ministry of Health Tanzania and National Health Mission Varanasi, to:
develop leaders, putting leadership into practice during online and in-person immersion programmes.
foster cross-sector innovation where partners develop and test innovative projects. These projects supports the government and NGO partners to reduce the burden of cervical cancer in the areas where we work.
NJIA in NUMBERS:
5 years of programmes
164 Roche participants
174 East African and Indian participants
63 innovations ideas tested
28,000 hours invested in leadership development
“Listening to the team presentations gave me goosebumps. Most of us here are very passionate about cervical cancer prevention and we constantly see this disease affecting women day in and day out. The concept of utilising leaders who are already there is THE solution to strengthening prevention services when resources are limited.”
